Commentary on “Solving the benign prostatic hyperplasia puzzle”

Commentary on “Solving the benign prostatic hyperplasia puzzle”

Saved in:

Bibliographic Details
Main Authors:	Dominique Thomas, Bilal Chughtai, Steven Kaplan
Format:	Article
Language:	English
Published:	Elsevier 2018-01-01
Series:	Asian Journal of Urology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214388216300686
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of photovaporization of the prostate in small volume benign prostatic hyperplasia and review of the literature
by: Dominique Thomas, et al.
Published: (2019-10-01)

Percutaneous cystolithotripsy for patients with benign prostatic hyperplasia
by: M. E. Topuzov, et al.
Published: (2021-12-01)

Laser technologies in surgery for benign prostate hyperplasia
by: S. A. Rakhimov, et al.
Published: (2024-03-01)

Emphasis on the management of embedded capsular hyperplasia nodules associated with benign prostatic hyperplasia
by: Chenghao Zheng, et al.
Published: (2025-07-01)

A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia.
by: Bilal Chughtai, et al.
Published: (2022-01-01)

Heterogeneity symptoms of urgency in patients with benign prostatic hyperplasia
by: V. L. Medvedev, et al.
Published: (2021-06-01)

Effect of benign prostatic hyperplasia surgery on ejaculatory function
by: M. P. Dianov, et al.
Published: (2024-04-01)

Ejaculation-sparing enucleation of benign prostate hyperplasia: is it almost feasible?
by: A. G. Martov, et al.
Published: (2023-04-01)

Personalized Approach to the Surgical Treatment of Benign Prostatic Hyperplasia by Bipolar Transurethral Resection of the Prostate
by: I. A. Chekhonatskii, et al.
Published: (2023-07-01)

Male sexuality and the risk of developing benign prostatic hyperplasia and prostate cancer: is there a connection?
by: M. I. Kogan, et al.
Published: (2025-07-01)

Silodosin — a safer alpha-blocker targeting benign prostatic hyperplasia
by: Karen Koch
Published: (2015-09-01)

The influence of metabolic syndrome on the development and clinical manifestations of benign prostatic hyperplasia
by: V. B. Filimonov, et al.
Published: (2018-12-01)

Is Canine Prostate-Specific Esterase a Reliable Marker for Benign Prostatic Hyperplasia Progression in Dogs?
by: Florin-Petrișor Posastiuc, et al.
Published: (2025-05-01)

Super-selective prostatic arteries embolization in patients with benign prostate hyperplasia: prevention and treatment of complications
by: B. M. Shaparov, et al.
Published: (2021-12-01)

Association of Androgenetic Alopecia with Benign Prostatic Hyperplasia: A Case Control Study
by: Manoj Kumar Chaudhary, et al.
Published: (2018-03-01)

Association of Androgenetic Alopecia with Benign Prostatic Hyperplasia: A Case Control Study
by: Manoj Kumar Chaudhary, et al.
Published: (2018-03-01)

Modern approaches to surgical and minimally invasive treatment of patients with benign prostate hyperplasia
by: A. A. Zimichev, et al.
Published: (2020-12-01)

MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation
by: Z. M. Akhokhov, et al.
Published: (2023-10-01)

Urinary dysfunction in patients with unsatisfactory results of surgical treatment of benign prostatic hyperplasia
by: S. Kh. Al-Shukri, et al.
Published: (2017-12-01)

Prostate volume, LUTS scale, and uroflowmetry of benign prostate hyperplasia patients with type 2 diabetes mellitus
by: A. N. Hakim, et al.
Published: (2024-11-01)

Doppler Ultrasonography in the Diagnosis of Dogs With Benign Prostatic Hyperplasia and Investigation of the Efficacy of Finasteride in Treatment
by: Burcu Esin, et al.
Published: (2025-05-01)

PHARMACOTHERAPY IN PATIENTS WITH ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA IN THE ABSENCE OF RISK OF DISEASE PROGRESSION
by: A. A. Kamalov, et al.
Published: (2018-03-01)

Transperineal laser ablation of the prostate as a treatment for benign prostatic hyperplasia and prostate cancer: The results of a Delphi consensus project
by: Andrea Cocci, et al.
Published: (2024-04-01)

Investigation on core-fucosylated prostate-specific antigen as a refined biomarker for differentiation of benign prostate hyperplasia and prostate cancer of different aggressiveness
by: Robert Lang, et al.
Published: (2019-03-01)

Thulium laser enucleation of the prostate plus thulium fiber laser therapy for benign prostatic hyperplasia combined with bladder stones
by: Chen Wang, et al.
Published: (2024-08-01)

Health technology assessment (HTA) of prostatic urethral lift (PUL) for the treatment of benign prostatic hyperplasia (BPH) in the Italian context
by: Agostino Fortunato, et al.
Published: (2025-07-01)

Association of life’s crucial 9 score with benign prostatic hyperplasia: a cross-sectional study
by: Haoran Wang, et al.
Published: (2025-05-01)

Hovenia dulcis Honey Suppresses Androgen‐Induced Epithelial–Mesenchymal Transition in Benign Prostatic Hyperplasia
by: Buyun Kim, et al.
Published: (2025-05-01)

Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus
by: Shahana Sarwar, et al.
Published: (2017-01-01)

Bladder drainage methods for acute urinary retention due to benign prostatic hyperplasia: patient-preference analysis
by: A. I. Volnukhin, et al.
Published: (2024-09-01)

Clinical portrait of an "ordinary" patient with benign prostatic hyperplasia and the efficacy of treating lower urinary tract symptoms
by: V. L. Medvedev, et al.
Published: (2023-04-01)

Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care, Port Harcourt, Nigeria
by: A.A. Bock-Oruma, et al.
Published: (2013-10-01)

PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA
by: N. A. Avxentyev, et al.
Published: (2016-09-01)

Assessment of novel biomarkers of renal dysfunction associated with lower urinary tract symptoms in men with benign prostatic hyperplasia
by: V. Yu. Startsev, et al.
Published: (2024-11-01)

Evaluation of serum alpha-1B glycoprotein and C-reactive protein levels as biomarkers of canine benign prostatic hyperplasia
by: Grisnarong Wongbandue, et al.
Published: (2025-06-01)

TNF-α modulates cell proliferation via SOX4/TGF-β/Smad signaling in benign prostatic hyperplasia
by: Jinze Li, et al.
Published: (2025-07-01)

Cooperative Game Theory of Hierarchies: One Approach to Solving the Low-Risk Puzzle?
by: Tobias Hiller
Published: (2025-04-01)

Impact of fatty liver index and metabolic dysfunction-associated steatotic liver disease on the risk of benign prostatic hyperplasia in older male adults
by: Fan Zhang, et al.
Published: (2025-08-01)

Cutting-edge assays for mirabegron and tadalafil combo therapy for benign prostatic hyperplasia; insilico kinetics approach; multi trait sustainability assessment
by: Sara I. Aboras, et al.
Published: (2025-05-01)

Dehydroepiandrosterone Decline in Aging Males as a Predictor of Erectile Dysfunction and Mood Disorders in Patients With Benign Prostate Hyperplasia Undergoing Dutasteride Treatment
by: Maja Sofronievska Glavinov, et al.
Published: (2025-08-01)